Skeletal muscle tissue from the Goto-Kakizaki rat model of type-2 diabetes exhibits increased levels of the small heat shock protein Hsp27

Molecular Medicine Reports

Volumn 4, Issue 2, 2011, Pages 229-236

  Mullen, Edel ^a   O'Reilly, Elaine ^a   Ohlendieck, Kay ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Difference in gel electrophoresis; Goto Kakizaki rat; Hsp27; Muscle proteomics; Type 2 diabetes

Indexed keywords

ALPHA ACTININ 2; ALPHA CRYSTALLIN; BIOLOGICAL MARKER; BISPHOSPHOGLYCERATE MUTASE; HEAT SHOCK PROTEIN 27; HEMOGLOBIN BETA CHAIN; MYOGLOBIN; MYOSIN HEAVY CHAIN; MYOSIN LIGHT CHAIN; TROPOMYOSIN; TROPONIN C; TROPONIN T;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DISEASE MARKER; GENE EXPRESSION REGULATION; GOTO KAKIZAKI RAT; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; INSULIN RESISTANCE; MASS SPECTROMETRY; MUSCLE LEVEL; MUSCLE WEAKNESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; RAT; SKELETAL MUSCLE; TWO DIMENSIONAL GEL ELECTROPHORESIS; VASCULAR RESISTANCE; WISTAR RAT;

AMINO ACID SEQUENCE; ANIMALS; DIABETES MELLITUS, TYPE 2; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HEAT-SHOCK PROTEINS, SMALL; HSP27 HEAT-SHOCK PROTEINS; IMMUNOBLOTTING; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; ORGANOMETALLIC COMPOUNDS; PEPTIDE MAPPING; PHENANTHROLINES; PROTEOMICS; RATS; TISSUE EXTRACTS;

RATTUS;

EID: 79551696981     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.437     Document Type: Article

References (58)

1. Sundsten T and Ortsater H: Proteomics in diabetes research. Mol Cell Endocrinol 297: 93-103, 2009.
2. Hojlund K, Wrzesinski K, Larsen PM, Fey SJ, Roepstorff P, Handberg A, Dela F, Vinten J, McCormack JG, Reynet C and Beck-Nielsen H: Proteome analysis reveals phosphorylation of ATP synthase beta-subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes. J Biol Chem 278: 10436-10442, 2003. (Pubitemid 36800309)
3. Stentz FB and Kitabchi AE: Transcriptome and proteome expressions involved in insulin resistance in muscle and activated T-lymphocytes of patients with type 2 diabetes. Genomics Proteomics Bioinformatics 5: 216-235, 2007. (Pubitemid 351215121)
4. Hwang H, Bowen BP, Lefort N, Flynn CR, De Filippis EA, Roberts C, Smoke CC, Meyer C, Hojlund K, Yi Z and Mandarino LJ: Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes mellitus. Diabetes 59: 33-42, 2010.
5. Mullen E and Ohlendieck K: Proteomic profiling of non-obese type 2 diabetic skeletal muscle. Int J Mol Med 25: 445-458, 2010.
6. Lefort N, Glancy B, Bowen B, Willis WT, Bailowitz Z, De Filippis EA, Brophy C, Meyer C, Hojlund K, Yi Z and Mandarino LJ: Increased reactive oxygen species production and lower abundance of complex I subunits and carnitine palmitoyltransferase 1B protein despite normal mitochondrial respiration in insulin-resistant human skeletal muscle. Diabetes 59: 2444-2452, 2010.
7. Mullen E and Ohlendieck K: Proteomic analysis of the mitochondria- enriched fraction from diabetic rat skeletal muscle. J Integ Omics: Nov 9, 2010 (E-pub ahead of print).
8. Petersen KF and Shulman GI: Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am J Cardiol 90: 11G-18G, 2002.
9. Phielix E and Mensink M: Type 2 diabetes mellitus and skeletal muscle metabolic function. Physiol Behav 94: 252-258, 2008. (Pubitemid 351615433)
10. Abdul-Ghani MA and DeFronzo RA: Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotech 2010: 476279, 2010.
11. Scheen AJ: Pathophysiology of type 2 diabetes. Acta Clin Belg 58: 335-341, 2003.
12. Sander GE and Giles TD: Diabetes mellitus and heart failure. Am Heart Hosp J 1: 273-280, 2003.
13. Tusie-Luna MT: Genes and type 2 diabetes mellitus. Arch Med Res 36: 210-222, 2005.
14. King H, Aubert RE and Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21: 1414-1431, 1998.
15. Wild S, Roglic G, Green A, Sicree R, and King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053, 2004
16. Gregg EW, Beckles GL, Williamson DF, Leveille SG, Langlois JA, Engelgau MM and Narayan KM: Diabetes and physical disability among US adults. Diabetes Care 23: 1272-1277, 2000.
17. Andersen H, Nielsen S, Mogensen CE and Jakobsen J: Muscle strength in type 2 diabetes. Diabetes 53: 1543-1548, 2004.
18. Park SW, Goodpaster BH, Strotmeyer ES, De Rekeneire N, Harris TB, Schwartz AV, Tylavsky FA and Newman AB: Decreased muscle strength and quality in older adults with type 2 diabetes. Diabetes 55: 1813-1818, 2006.
19. Park SW, Goodpaster BH, Lee JS, Kuller LH, Boudreau R, De Rekeneire N, Harris TB, Kritchevsky S, Tylavsky FA, Nevitt M, Cho YW and Newman AB: Health, aging, and body composition study: excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care 32: 1993-1997, 2009.
20. 2+-handling apparatus in diabetes-related muscle weakness (Review). Mol Med Rep 1: 297-306, 2008.
21. Issaq H and Veenstra T: Two-dimensional Polyacrylamide gel electrophoresis (2D-PAGE): advances and perspectives. Biotechniques 44: 697-700, 2008. (Pubitemid 351656291)
22. Weiss W and Gorg A: High-resolution two-dimensional electrophoresis. Methods Mol Biol 564: 13-32, 2009.
23. Westermeier R and Schickle H: The current state of the art in high-resolution two-dimensional electrophoresis. Arch Physiol Biochem 115: 279-285, 2009.
24. Gorg A, Weiss W and Dunn MJ: Current two-dimensional electrophoresis technology for proteomics. Proteomics 4: 3665-3685, 2004. (Pubitemid 39657447)
25. Wittmann-Liebold B, Graack HR and Pohl T: Two-dimensional gel electrophoresis as tool for proteomics studies in combination with protein identification by mass spectrometry. Proteomics 6: 4688-4703, 2006. (Pubitemid 44369049)
26. Rabilloud T, Vaezzadeh AR, Potier N, Lelong C, Leize-Wagner E and Chevallet M: Power and limitations of electrophoretic separations in proteomics strategies. Mass Spectrom Rev 28: 816-843, 2009.
27. Domon B and Aebersold R: Mass spectrometry and protein analysis. Science 312: 212-217, 2006.
28. Canas B, Lopez-Ferrer D, Ramos-Fernandez A, Camafeita E and Calvo E: Mass spectrometry technologies for proteomics. Brief Funct Genomic Proteomic 4: 295-320, 2006.
29. Kitahara A, Toyota T, Kakizaki M and Goto Y: Activities of hepatic enzymes in spontaneous diabetes rats produced by selective breeding of normal Wistar rats. Tohoku J Exp Med 126: 7-11, 1978. (Pubitemid 9006922)
30. Abdel-Halim SM, Guenifi A, Luthman H, Grill V, Efendic S and Ostenson CG: Impact of diabetic inheritance on glucose tolerance and insulin secretion in spontaneously diabetic GK-Wistar rats. Diabetes 43: 281-288, 1994.
31. Portha B, Serradas P, Bailbe D, Suzuki K, Goto Y and Giroix MH: Beta-cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes. Diabetes 40: 486-491, 1991.
32. Witte K, Jacke K, Stahrenberg R, Arlt G, Reitenbach I, Schilling L and Lemmer B: Dysfunction of soluble guanylyl cyclase in aorta and kidney of Goto-Kakizaki rats: influence of age and diabetic state. Nitric Oxide 6: 85-95, 2002. (Pubitemid 34848269)
33. Krook A, Kawano Y, Song XM, Efendic S, Roth RA, Wallberg-Henriksson H and Zierath JR: Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki rats. Diabetes 46: 2110-2114, 1997. (Pubitemid 27512106)
34. Dadke SS, Li HC, Kusari AB, Begum N and Kusari J: Elevated expression and activity of protein-tyrosine phosphatase 1B in skeletal muscle of insulin-resistant type II diabetic Goto-Kakizaki rats. Biochem Biophys Res Comm 274: 583-589, 2000. (Pubitemid 30663664)
35. Yasuda K, Nishikawa W, Iwanaka N, Nakamura E, Seino Y, Tsuda K and Ishihara A: Abnormality in fibre type distribution of soleus and plantaris muscles in non-obese diabetic Goto-Kakizaki rats. Clin Exp Pharmacol Physiol 29: 1001-1008, 2002. (Pubitemid 35177168)
36. Steiler TL, Galuska D, Leng Y, Chibalin AV, Gilbert M and Zierath JR: Effect of hyperglycemia on signal transduction in skeletal muscle from diabetic Goto-Kakizaki rats. Endocrinology 44: 5259-5267, 2003. (Pubitemid 37476054)
37. Mulvey C, Harno E, Keenan A and Ohlendieck K: Expression of the skeletal muscle dystrophin-dystroglycan complex and syntrophin-nitric oxide synthase complex is severely affected in the type 2 diabetic Goto-Kakizaki rat. Eur J Cell Biol 84: 867-883, 2005. (Pubitemid 41574431)
38. Shen W, Hao J, Tian C, Ren J, Yang L, Li X, Luo C, Cotma CW and Liu J: A combination of nutriments improves mitochondrial biogenesis and function in skeletal muscle of type 2 diabetic goto-kakizaki rats. PLoS One 3, e2328, 2008.
39. Nishimura RN and Sharp FR: Heat shock proteins and neuro-muscular disease. Muscle & Nerve 32: 693-709, 2005. (Pubitemid 41746258)
40. Golenhofen N, Perng MD, Quinlan RA and Drenckhahn D: Comparison of the small heat shock proteins alphaB-crystallin, MKBP, HSP25, HSP20, and cvHSP in heart and skeletal muscle. Histochem Cell Biol 122: 415-425, 2004. (Pubitemid 40379011)
41. Nicholl ID and Quinlan RA: Chaperone activity of alpha-crystallins modulates intermediate filament assembly. EMBO J 13: 945-953, 1994.
42. Van Montfort R, Slingsby C and Vierling E: Structure and function of the small heat shock protein/alpha-crystallin family of molecular chaperones. Adv Protein Chem 59: 105-156, 2001. (Pubitemid 34169303)
43. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
44. Donoghue P, Doran P, Wynne K, Pedersen K, Dunn MJ and Ohlendieck K: Proteomic profiling of chronic low-frequency stimulated fast muscle. Proteomics 7: 3417-3430, 2007. (Pubitemid 47517956)
45. Doran P, Martin G, Dowling P, Jockusch H and Ohlendieck K: Proteome analysis of the dystrophin-deficient MDX diaphragm reveals a drastic increase in the heat shock protein cvHSP. Proteomics 6: 4610-4621, 2006. (Pubitemid 44336975)
46. Doran P, O'Connell K, Gannon J, Kavanagh M and Ohlendieck K: Opposite pathobiochemical fate of pyruvate kinase and adenylate kinase in aged rat skeletal muscle as revealed by proteomic DIGE analysis. Proteomics 8: 364-377, 2008. (Pubitemid 351212333)
47. Karp NA and Lilley KS: Maximising sensitivity for detecting changes in protein expression: experimental design using minimal CyDyes. Proteomics 5: 3105-3115, 2005. (Pubitemid 41176477)
48. Rabilloud T, Strub JM, Luche S, van Dorsselaer A and Lunardi J: A comparison between Sypro Ruby and ruthenium II tris (bathophenanthroline disulfonate) as fluorescent stains for protein detection in gels. Proteomics 1: 699-704, 2001. (Pubitemid 33588320)
49. Gannon J, Staunton L, O'Connell K, Doran P and Ohlendieck K: Phosphoproteomic analysis of aged skeletal muscle. Int J Mol Med 22: 33-42, 2008.
50. Staples GO, Bowman MJ, Costello CE, Hitchcock AM, Lau JM, Leymarie N, Miller C, Naimy H, Shi X and Zaia J: A chipbased amide-HILIC LC/MS platform for glycosaminoglycan glycomics profiling. Proteomics 9: 686-695, 2009.
51. Tonge R, Shaw J, Middleton B, Rowlinson R, Rayner S, Young J, Pognan F, Hawkins E, Currie I and Davison M: Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 1: 377-396, 2001. (Pubitemid 33585112)
52. Marouga R, David S and Hawkins E: The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem 382: 669-678, 2005. (Pubitemid 40890994)
53. Viswanathan S, Unlu M and Minden JS: Two-dimensional difference gel electrophoresis. Nat Protoc 1: 1351-1358, 2006.
54. Doran P, Gannon J, O'Connell K and Ohlendieck K: Proteomic profiling of animal models mimicking skeletal muscle disorders. Proteomics Clin Appl 1: 1169-1184, 2007.
55. Miao L and St Clair DK: Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med 47: 344-356, 2009.
56. Doran P, Gannon J, O'Connell K and Ohlendieck K: Aging skeletal muscle shows a drastic increase in the small heat shock proteins αB-crystallin/ HspB5 and cvHsp/HspB7. Eur J Cell Biol 86: 629-640, 2007. (Pubitemid 47408714)
57. Ohlendieck K: Proteomics of skeletal muscle differentiation, neuromuscular disorders and fiber aging. Expert Rev Proteomics 7: 283-296, 2010.
58. Korc M: Diabetes mellitus in the era of proteomics. Mol Cell Proteomics 2: 399-404, 2003.